Search Results - "Shi, V.C"

Serum uric acid, influence of sacubitril/valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF by Selvaraj, S, Claggett, B.L, Veldhuisen, D.V, Anand, I.S, Pieske, B, Rouleau, J.L, Zile, M.R, Shi, V.C, Lefkowitz, M.P, McMurray, J.J.V, Solomon, S.D

“…Abstract Background Serum uric acid (SUA) is a biomarker of several pathobiologies relevant to the pathogenesis of heart failure with preserved ejection…”
Get full text

Reduced cognitive function is associated with poor outcomes in HFpEF: a post hoc analysis from PARAGON-HF by Dewan, P, Jhund, P.S, Anand, I.S, Desai, A.S, Pieske, B, Rizkala, A.R, Shah, S.J, Shi, V.C, Van Veldhuisen, D.J, Zannad, F, Zile, M.R, Solomon, S.D, McMurray, J.J.V

“…Abstract Background Little is known about the prevalence and consequences of cognitive impairment in patients with heart failure and preserved ejection…”
Get full text

Global differences in heart failure with preserved ejection fraction: the paragon-hf trial by Tromp, J, Clagget, B.L, Jhund, P, Kober, L, Widimsky, J, Chopra, V, Ge, J, Maggioni, A.P, Martinez, F, Zannad, F, Lefkowitz, M.P, Shi, V.C, McMurray, J.J.V, Solomon, S.D, Lam, C.S.P

“…Abstract Background Heart failure with preserved ejection fraction (HFpEF) is a global public health problem with important regional differences. We…”
Get full text